Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label single-arm study of ALMB-0168 in osteosarcoma
CTR20210451Phase 2Active
- Sponsor
- Enlemai
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ALMB-0168 in osteosarcoma (OS), sponsored by Enlemai. Started Sep 2021; status: active.
02
Drugs
ALMB-0168
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on CTR20210451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210451.